Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $199.1 million.

  • Cross Country Healthcare's Cost of Revenue fell 2065.5% to $199.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $899.9 million, marking a year-over-year decrease of 2143.09%. This contributed to the annual value of $1.1 billion for FY2024, which is 3183.33% down from last year.
  • According to the latest figures from Q3 2025, Cross Country Healthcare's Cost of Revenue is $199.1 million, which was down 2065.5% from $218.1 million recorded in Q2 2025.
  • Over the past 5 years, Cross Country Healthcare's Cost of Revenue peaked at $613.9 million during Q1 2022, and registered a low of $199.1 million during Q3 2025.
  • Over the past 5 years, Cross Country Healthcare's median Cost of Revenue value was $301.9 million (recorded in 2024), while the average stood at $356.4 million.
  • Per our database at Business Quant, Cross Country Healthcare's Cost of Revenue skyrocketed by 20613.28% in 2021 and then plummeted by 3753.63% in 2024.
  • Over the past 5 years, Cross Country Healthcare's Cost of Revenue (Quarter) stood at $493.5 million in 2021, then decreased by 0.86% to $489.3 million in 2022, then crashed by 33.87% to $323.5 million in 2023, then fell by 23.37% to $247.9 million in 2024, then dropped by 19.69% to $199.1 million in 2025.
  • Its last three reported values are $199.1 million in Q3 2025, $218.1 million for Q2 2025, and $234.8 million during Q1 2025.